Literature DB >> 30863609

Is segmentectomy the future?

Rodney J Landreneau1, Matthew J Schuchert1.   

Abstract

The role of anatomic segmentectomy as an acceptable, lung parenchymal sparing alternative to pulmonary lobectomy for the small peripheral stage I lung cancer is under great scrutiny today. This is not a new consideration, particularly for the patient with impaired cardiopulmonary reserve where preservation of lung function may be a critical issue in deciding on surgical resection for local/regional control of their cancer. In this review, we discuss the oncologic issues along with past and present evidence supporting "anatomic" lung preservational surgery in the management of lung cancer.

Entities:  

Keywords:  Lung cancer; anatomic resection; segmentectomy; sublobar resection; surgery

Year:  2019        PMID: 30863609      PMCID: PMC6384380          DOI: 10.21037/jtd.2018.12.67

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  60 in total

Review 1.  The history of lobectomy and segmentectomy including sleeve resection.

Authors:  C F Kittle
Journal:  Chest Surg Clin N Am       Date:  2000-02

2.  Norman Bethune and Edward Archibald: sung and unsung heroes.

Authors:  L D MacLean; M A Entin
Journal:  Ann Thorac Surg       Date:  2000-11       Impact factor: 4.330

3.  Pneumonectomy and lobectomy in bronchogenic carcinoma. A comparison of end results of the Overholt and Ochsner clinics.

Authors:  M B SHIMKIN; R R CONNELLY; S C MARCUS; S J CUTLER
Journal:  J Thorac Cardiovasc Surg       Date:  1962-10       Impact factor: 5.209

4.  Comparison between clinical and pathologic staging in 2,994 cases of lung cancer.

Authors:  Angel López-Encuentra; Ricardo García-Luján; Juan José Rivas; Jesús Rodríguez-Rodríguez; Juan Torres-Lanza; Gonzalo Varela-Simo
Journal:  Ann Thorac Surg       Date:  2005-03       Impact factor: 4.330

5.  Functional advantage after radical segmentectomy versus lobectomy for lung cancer.

Authors:  Hiroaki Harada; Morihito Okada; Toshihiko Sakamoto; Hidehito Matsuoka; Noriaki Tsubota
Journal:  Ann Thorac Surg       Date:  2005-12       Impact factor: 4.330

6.  Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database.

Authors:  Carlos M Mery; Anastasia N Pappas; Raphael Bueno; Yolonda L Colson; Philip Linden; David J Sugarbaker; Michael T Jaklitsch
Journal:  Chest       Date:  2005-07       Impact factor: 9.410

7.  Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller?

Authors:  M Okada; K Yoshikawa; T Hatta; N Tsubota
Journal:  Ann Thorac Surg       Date:  2001-03       Impact factor: 4.330

8.  Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection.

Authors:  Morihito Okada; Wataru Nishio; Toshihiko Sakamoto; Kazuya Uchino; Tsuyoshi Yuki; Akio Nakagawa; Noriaki Tsubota
Journal:  J Thorac Cardiovasc Surg       Date:  2005-01       Impact factor: 5.209

Review 9.  Segmental resection spares pulmonary function in patients with stage I lung cancer.

Authors:  Robert J Keenan; Rodney J Landreneau; Richard H Maley; Deepak Singh; Robin Macherey; Susan Bartley; Tibetha Santucci
Journal:  Ann Thorac Surg       Date:  2004-07       Impact factor: 4.330

10.  A new method of segmental resection for primary lung cancer: intermediate results.

Authors:  T Bando; K Yamagihara; Y Ohtake; R Miyahara; F Tanaka; S Hasegawa; K Inui; Hiromi Wada
Journal:  Eur J Cardiothorac Surg       Date:  2002-05       Impact factor: 4.191

View more
  3 in total

1.  Consistency of radiologists in identifying pulmonary nodules based on low-dose computed tomography.

Authors:  Shuai Ming; Wei Yang; Si-Jia Cui; Shuai Huang; Xiang-Yang Gong
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

2.  Lobectomy versus segmentectomy in patients with stage T (> 2 cm and ≤ 3 cm) N0M0 non-small cell lung cancer: a propensity score matching study.

Authors:  Linlin Wang; Lihui Ge; Sibo You; Yongyu Liu; Yi Ren
Journal:  J Cardiothorac Surg       Date:  2022-05-11       Impact factor: 1.522

3.  Evolution of the surgical treatment of lung cancer at a tertiary referral center in Brazil, 2011-2018.

Authors:  Mariana Schettini Soares; Laura Maria Coltro; Pedro Henrique Cunha Leite; Priscila Berenice Costa; Letícia Leone Lauricella; Paulo Manuel Pêgo-Fernandes; Ricardo Mingarini Terra
Journal:  J Bras Pneumol       Date:  2020-12-16       Impact factor: 2.624

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.